Rice bran arabinoylan compound study
This study is examining if a rice bran supplement improves the quality of life of cancer patients during treatment.
Rice bran arabinoxylan compound (RBAC) is a food supplement known to affect the body’s ability to defend against germs and cancerous cells.
During cancer treatment, RBAC may also help to reduce side effects, make patients feel better, and may improve treatment results.
However, there hasn't been enough research done to prove this. This study will examine whether RBAC does provide benefits during cancer treatment.
What does the clinical trial involve?
Researchers are seeking participants who are aged 18 years or older, who have been diagnosed with cancer (stage II and above) and are currently receiving cancer treatment.
Participants will take either the supplement or dummy powder for six months and will also be asked to complete the following items five times during the study:
- Online questionnaires
- blood tests
- body scans
- stool sample collections
How can people take part in the clinical trial?
The study will be carried out at three locations:
| Location | Principal Investigator | Trial resources |
|---|---|---|
Daffodil Cottage Cancer Service - Bathurst Health Service 365 Howick St, West Bathurst NSW 2795 | Dr Rob Zielinski | |
Central West Cancer Centre - Orange Health Service 1502 Forest Road, Orange, NSW 2800 | Dr Rob Zielinski | |
Chris O'Brien Lifehouse 119-143 Missenden Road, Camperdown NSW 2050 | Associate Professor Judith Lacey |
Express your interest in taking part
If you are interested in taking part in this trial, please fill in our expression of interest form.
For more information about the wider study
For for more information please contact:
Dr Sok Cheon Pak
Lead Researcher
Phone: (02) 6338 4952
Email: spak@csu.edu.au
Publications relating to this research
Ooi, S. L., Pak, S. C., Micalos, P. S., Schupfer, E., Lockley, C., Park, M. H., & Hwang, S.-J. (2021). The health-promoting properties and clinical applications of rice bran arabinoxylan modified with shiitake mushroom enzyme—A narrative review. Molecules, 26(9), 2539. https://doi.org/10.3390/molecules26092539
Schupfer, E., Pak, S. C., Wang, S., Micalos, P. S., Jeffries, T., Ooi, S. L., Golombick, T., Harris, G., & El-Omar, E. (2021). The effects and benefits of arabinoxylans on human gut microbiota – A narrative review. Food Bioscience, 43, 101267. https://doi.org/https://doi.org/10.1016/j.fbio.2021.101267
Ooi, S. L., Pak, S. C., Micalos, P. S., Schupfer, E., Zielinski, R., Jeffries, T., Harris, G., Golombick, T., & McKinnon, D. (2020). Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial. Contemporary Clinical Trials Communications, 19,100580. https://doi.org/10.1016/j.conctc.2020.100580